Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 7, 2011, Pages 389-397

  Togami, Kohei ^a   Chono, Sumio ^a   Morimoto, Kazuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

alveolar macrophages; azithromycin; clarithromycin; lung epithelial lining fluid; macrolide antimicrobial agents

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TRANSPORT; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MALE; NONHUMAN; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; AZITHROMYCIN; BODY FLUIDS; CELL LINE; CLARITHROMYCIN; LUNG; MACROPHAGES, ALVEOLAR; RATS; RESPIRATORY MUCOSA; TISSUE DISTRIBUTION;

EID: 80053179622     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.767     Document Type: Article

References (41)

1. Kucukbasmaci O, Gonullu N, Aktas Z, Gurol D, Berkiten R,. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Int J Antimicrob Agents 2003; 22: 497-501. doi: 10.1016/S0924-8579(03)00150-X. (Pubitemid 37356950)
2. Yamaguchi T, Hirakata Y, Izumikawa K, et al., In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan. Antimicrob Agents Chemother 2000; 44: 1381-1382. (Pubitemid 30228328)
3. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, Mcdonald EJ, Fernandes PB,. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988; 32: 1710-1719. (Pubitemid 18267620)
4. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T,. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 2003; 52: 497-499. doi: 10.1093/jac/dkg371. (Pubitemid 37120735)
5. Suwa T, Yoshida H, Kohno Y, Yoshitomi S, Ohta K,. Metabolic fate of TE-031(III) Absorption, distribution and excretion of 14C-TE-031 in rats, mice and dogs. Jpn J Chemother 1988; 36: 213-226.
6. Muto H, Kuboe Y, Kimira Y, et al., Pharmacokinetic study of azithromycin in experimental animals. Jpn J Chemother 1995; 43: 110-121. (Pubitemid 26041497)
7. Baldwin DR, Honeybourne D, Wise R,. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992; 36: 1171-1175.
8. Wilson R, Dowling RB, Jackson AD,. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 1996; 9: 1523-1530. (Pubitemid 26233800)
9. Densen P, Mandell GL,. Phagocyte strategy vs. microbial tactics. Rev Infect Dis 1980; 2: 817-838.
10. Swanson MS, Fernandez-Moreira E,. A microbial strategy to multiply in macrophages: the pregnant pause. Traffic 2002; 3: 170-177. doi: 10.1034/j.1600-0854.2002.030302.x. (Pubitemid 34555474)
11. Mckinney JD, Honer Zu Bentrup K, Munoz-Elias EJ, et al., Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000; 406: 735-738. doi: 10.1038/35021074.
12. Yamaguchi H, Haranaga S, Widen R, Friedman H, Yamamoto Y,. Chlamydia pneumonia infection induces differentiation of monocytes into macrophages. Infect Immun 2002; 70: 2392-2398. doi: 10.1128/IAI.70.5.2392-2398.2002. (Pubitemid 34408380)
13. Patel KB, Xuan D, Tessier PR, Russomanno JH, Quintiliani R, Nightingale CH,. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996; 40: 2375-2379. (Pubitemid 26328049)
14. Ball P, Baquero F, Cars O, et al., Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002; 49: 31-40. doi: 10.1093/jac/49.1.31. (Pubitemid 34100644)
15. Butts JD,. Intracellular concentrations of antibacterial agents and related clinical implications. Clin Pharmacokinet 1994; 27: 63-84. (Pubitemid 24211097)
16. Antonini JM, Reasor MJ,. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol 1991; 42: S151-S156.
17. Rennard SI, Basset G, Lecossier D, et al., Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-538. (Pubitemid 16019939)
18. Kohno Y, Yoshida H, Suwa T, Suga T,. Uptake of clarithromycin by rat lung cells. J Antimicrob Chemother 1990; 26: 503-513. (Pubitemid 20346866)
19. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
20. Feng NH, Hacker A, Effros RM,. Solute exchange between the plasma and epithelial lining fluid of rat lungs. J Appl Physiol 1992; 72: 1081-1089.
21. Widdicombe J,. Airway and alveolar permeability and surface liquid thickness: theory. J Appl Physiol 1997; 82: 3-12. (Pubitemid 27052036)
22. Wang F, Daugherty B, Keise LL, et al., Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 2003; 29: 62-70. (Pubitemid 36783317)
23. Forbes B, Ehrhardt C,. Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005; 60: 193-205. doi: 10.1016/j.ejpb.2005.02.010. (Pubitemid 40804561)
24. Sakagami M,. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006; 58: 1030-1060. doi: 10.1016/j.addr.2006.07.012. (Pubitemid 44712023)
25. Endter S, Becker U, Daum N, et al., P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers. Cell Tissue Res 2007; 328: 77-84. doi: 10.1007/s00441-006-0346-6. (Pubitemid 46411916)
26. Hamilton KO, Topp E, Makagiansar I, Siahaan T, Yazdanian M, Audus KL,. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther 2001; 298: 1199-1205. (Pubitemid 32761940)
27. Scheffer GL, Pijnenborg AC, Smit EF, et al., Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002; 55: 332-339. (Pubitemid 34494170)
28. Pachot JI, Botham RP, Haegele KD, Hwang K,. Experimental estimation of the role of P-glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. J Pharm Pharm Sci 2003; 6: 1-12. (Pubitemid 37207237)
29. Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham MJ,. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005; 49: 2372-2377. doi: 10.1128/AAC.49.6.2372-2377.2005. (Pubitemid 40734469)
30. Carlier MB, Garcia-Luque I, Montenez JP, Tulkens PM, Piret J,. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int J Tissue React 1994; 16: 211-220.
31. Hand WL, Hand DL,. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int J Antimicrob Agents 2001; 18: 419-425. doi: 10.1016/S0924-8579(01)00430-7. (Pubitemid 33065652)
32. Mandell GL, Coleman E,. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001; 45: 1794-1798. doi: 10.1128/AAC.45.6.1794-1798.2001. (Pubitemid 32466350)
33. Hand WL, King-Thompson N, Holman JW,. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1987; 31: 1553-1557. (Pubitemid 17140810)
34. Laufen H, Wildfeuer A,. Kinetics of the uptake of antimicrobial agents by human polymorphonuclear leucocytes. Arzneimittelforschung 1989; 39: 233-235. (Pubitemid 19055372)
35. Vazifeh D, Abdelghaffar H, Labro MT,. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob Agents Chemother 1997; 41: 2099-2107. (Pubitemid 27422197)
36. Vazifeh D, Abdelghaffar H, Labro MT,. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob Agents Chemother 2002; 46: 1364-1374. doi: 10.1128/AAC.46.5.1364-1374.2002. (Pubitemid 34415316)
37. Renard C, Vanderhaeghe HJ, Claes PJ, Zenebergh A, Tulkens PM,. Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother 1987; 31: 410-416. (Pubitemid 17027130)
38. Milne MD, Scribner BH, Crawford MA,. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med 1958; 24: 709-729.
39. Vestal RE, Kornhauser DM, Shand DG,. Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines. J Pharmacol Exp Ther 1980; 214: 106-111. (Pubitemid 10032390)
40. Raupach T, Ballanyi K,. Intracellular pH and KATP channel activity in dorsal vagal neurons of juvenile rats in situ during metabolic disturbances. Brain Res 2004; 1017: 137-145. doi: 10.1016/j.brainres.2004.05.030. (Pubitemid 38917153)
41. Chanteux H, Paternotte I, Mingeot-Leclercq MP, Brasseur R, Sonveaux E, Tulkens PM,. Cell handling, membrane-binding properties, and membrane-penetration modeling approaches of pivampicillin and phthalimidomethylampicillin, two basic esters of ampicillin, in comparison with chloroquine and azithromycin. Pharm Res 2003; 20: 624-631. doi: 10.1023/A:1023203017300. (Pubitemid 36438907)